← FDA Drug Approvals (Drugs@FDA)

NALOXONE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-10-26

Drug application

FDA Application #
ANDA216624
Application type
Abbreviated New Drug Application (Generic)
Brand name
NALOXONE HYDROCHLORIDE
Generic name
Naloxone Hydrochloride
Active ingredients
NALOXONE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
ACCORD HLTHCARE
First approval
2022-10-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown